• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Greenhill & Co. Inc. (Amendment)

    1/20/22 4:22:55 PM ET
    $GHL
    Investment Bankers/Brokers/Service
    Finance
    Get the next $GHL alert in real time by email
    SC 13D/A 1 d287671dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    Schedule 13D

    (Rule 13d-101)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(a) and Amendments Thereto Filed

    Pursuant to § 240.13d-2(a)

    Under the Securities Exchange Act of 1934

    (Amendment No. 5)*

     

     

    Greenhill & Co., Inc.

    (Name of Issuer)

    Common Stock, par value $0.01 per share

    (Title of Class of Securities)

    395259104

    (CUSIP Number)

     

     

    Robert F. Greenhill

    c/o Greenhill & Co., Inc.

    1271 Avenue of the Americas

    New York, New York 10020

    (212) 389-1500

     

     

    with a copy to:

    Harold J. Rodriguez, Jr.

    Greenhill & Co., Inc.

    1271 Avenue of the Americas

    New York, New York 10020

    (212) 389-1500

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    November 8, 2021

    (Date of Event which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ☐.

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

     

     

     


    CUSIP No. 395259104    13D    Page 1 of 8

     

      1    

      Names of Reporting Persons

     

      Robert F. Greenhill

      2  

      Check the Appropriate Box If a Member of a Group (See Instructions)

      a.  ☒        b.  ☐

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      AF, OO

      5  

      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      United States of America

    Number of

    Shares

     Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

     

         7     

      Sole Voting Power

     

      425,212

         8   

      Shared Voting Power

     

      2,028,684

         9   

      Sole Dispositive Power

     

      425,212

       10   

      Shared Dispositive Power

     

      2,028,684

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      2,453,896

    12  

      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13  

      Percent of Class Represented By Amount in Row (11)

     

      13.7%

    14  

      Type of Reporting Person (See Instructions)

     

      IN


    CUSIP No. 395259104    13D    Page 2 of 8

     

      1    

      Names of Reporting Persons

     

      Greenhill Family Limited Partnership

      2  

      Check the Appropriate Box If a Member of a Group (See Instructions)

      a.  ☒        b.  ☐

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      AF

      5  

      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

     

         7     

      Sole Voting Power

     

      None

         8   

      Shared Voting Power

     

      989,524

         9   

      Sole Dispositive Power

     

      None

       10   

      Shared Dispositive Power

     

      989,524

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      989,524

    12  

      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13  

      Percent of Class Represented By Amount in Row (11)

     

      5.5%

    14  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 395259104    13D    Page 3 of 8

     

      1    

      Names of Reporting Persons

     

      Riversville Aircraft Corporation II

      2  

      Check the Appropriate Box If a Member of a Group (See Instructions)

      a.  ☒        b.  ☐

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      AF

      5  

      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

     

         7     

      Sole Voting Power

     

      None

         8   

      Shared Voting Power

     

      239,680

         9   

      Sole Dispositive Power

     

      None

       10   

      Shared Dispositive Power

     

      239,680

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      239,680

    12  

      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13  

      Percent of Class Represented By Amount in Row (11)

     

      1.3%

    14  

      Type of Reporting Person (See Instructions)

     

      CO


    CUSIP No. 395259104    13D    Page 4 of 8

     

      1    

      Names of Reporting Persons

     

      Socatean Partners

      2  

      Check the Appropriate Box If a Member of a Group (See Instructions)

      a.  ☒        b.  ☐

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      WC

      5  

      Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Connecticut

    Number of

    Shares

     Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

     

         7     

      Sole Voting Power

     

      None

         8   

      Shared Voting Power

     

      799,480

         9   

      Sole Dispositive Power

     

      None

       10   

      Shared Dispositive Power

     

      799,480

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      799,480

    12  

      Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

     

      ☐

    13  

      Percent of Class Represented By Amount in Row (11)

     

      4.5%

    14  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 395259104    13D    Page 5 of 8

     

    Explanatory Note

    The purpose of this Amendment No. 5 (the “Amendment No. 5”) to the Schedule 13D filed with the U.S. Securities and Exchange Commission on November 17, 2017, as amended on May 25, 2018, September 4, 2018, November 15, 2018 and October 17, 2019 (the “Schedule 13D”) is to reflect an increase in the percentage of the shares of Common Stock, par value $0.01 per share (the “Shares”), of Greenhill & Co., Inc., a Delaware corporation (the “Issuer”), beneficially owned by the Reporting Persons. The increase in the percentage of the Shares beneficially owned by the Reporting Persons since the Schedule 13D was last amended on October 17, 2019 is attributable to (i) Robert F. Greenhill receiving 71,564 Shares on February 6, 2020 from the settlement of vested Restricted Stock Units (140,821 Restricted Stock Units vested and 69,257 Shares were withheld to satisfy applicable tax withholding obligations) and (ii) a decrease in the outstanding Shares. Except as set forth below, all Items of the Schedule 13D remain unchanged. Capitalized terms used in this Amendment No. 5 and not otherwise defined shall have the respective meanings assigned to such terms in the Schedule 13D.

    Item 2. Identity and Background.

    Item 2 is hereby amended to reflect that (i) Robert F. Greenhill has ceased to be Senior Chairman of the Issuer and is now Chairman Emeritus of the Issuer and (ii) the address of each of the Reporting Persons has ceased to be c/o Greenhill & Co., Inc., 300 Park Avenue, New York, NY 10022 and is now c/o Greenhill & Co., Inc., 1271 Avenue of the Americas, New York, NY 10020.

    Item 3. Source and Amount of Funds or Other Consideration.

    Item 3 is hereby amended to add the following:

    On February 6, 2020, Robert F. Greenhill received 71,564 Shares from the settlement of vested Restricted Stock Units (140,821 Restricted Stock Units vested and 69,257 Shares were withheld to satisfy applicable tax withholding obligations). This transaction was made pursuant to the Prior Plan (as defined in Item 6).

    Item 4. Purpose of Transaction.

    The second sentence of the first paragraph under Item 4 is hereby amended and restated as follows:

    Robert F. Greenhill is the founder, former Chief Executive Officer, former Chairman of the Board of Directors, former Senior Chairman and current Chairman Emeritus of the Issuer.

    Item 5. Interest in Securities of the Issuer.

    Item 5 is hereby amended and restated as follows:

    (a) See Item 9 on the Cover Pages to this Amendment No. 5. Percentages are based on 17,919,275 Shares outstanding as of January 18, 2022.


    CUSIP No. 395259104    13D    Page 6 of 8

     

    As of the date hereof, the Reporting Persons beneficially own 2,453,896 Shares as a group, representing approximately 13.7% of the outstanding Shares.

    Robert F. Greenhill. Robert F. Greenhill is the direct beneficial owner of 425,212 Shares, representing approximately 2.4% of the outstanding Shares.

    Greenhill Family Limited Partnership. Robert F. Greenhill controls Greenhill Family Limited Partnership. Greenhill Family Limited Partnership is the direct beneficial owner of 989,524 Shares, representing approximately 5.5% of the outstanding Shares.

    Riversville Aircraft Corporation II. Robert F. Greenhill controls Riversville Aircraft Corporation II. Riversville Aircraft Corporation II is the direct beneficial owner of 239,680 Shares, representing approximately 1.3% of the outstanding Shares.

    Socatean Partners. Robert F. Greenhill controls Socatean Partners. Socatean Partners is the direct beneficial owner of 799,480 Shares, representing approximately 4.5% of the outstanding Shares.

    (b) Number of Shares as to which each Reporting Person has:

     

      (i)

    Sole power to vote or to direct the vote: See item 7 on the Cover Pages to this Amendment No. 5.

     

      (ii)

    Shared power to vote or to direct the vote: See item 8 on the Cover Pages to this Amendment No. 5.

     

      (iii)

    Sole power to dispose or to direct the disposition: See item 9 on the Cover Pages to this Amendment No. 5.

     

      (iv)

    Shared power to dispose or to direct the disposition: See item 10 on the Cover Pages to this Amendment No. 5.

    (c) On February 6, 2020, Robert F. Greenhill received 71,564 Shares from the settlement of vested Restricted Stock Units (140,821 Restricted Stock Units vested and 69,257 Shares were withheld to satisfy applicable tax withholding obligations).

    Except as described in this Item 5(c), there have been no transactions in Shares effected during the past 60 days by any of the Reporting Persons.


    CUSIP No. 395259104    13D    Page 7 of 8

     

    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Date: January 20, 2022    

     

    Robert F. Greenhill
    By:   /s/ Robert F. Greenhill
    Name:   Robert F. Greenhill
    Greenhill Family Limited Partnership
    By:   /s/ Robert F. Greenhill
    Name:   Robert F. Greenhill
    Title:   General Partner
    Riversville Aircraft Corporation II
    By:   /s/ Robert F. Greenhill
    Name:   Robert F. Greenhill
    Title:   President
    Socatean Partners
    By:   /s/ Robert F. Greenhill
    Name:   Robert F. Greenhill
    Title:   Managing General Partner


    EXHIBIT INDEX

     

    Exhibit
    Number
      

    Description

    1    Amended and Restated Equity Incentive Plan (incorporated by reference to Exhibit A to the Issuer’s Definitive Proxy Statement on Schedule 14A, filed on March 13, 2015).*
    2    Joint Filing Agreement, dated November 17, 2017, by and among the Reporting Persons.*
    3    Greenhill & Co., Inc. 2019 Equity Incentive Plan (incorporated by reference to Exhibit A to the Issuer’s Definitive Proxy Statement on Schedule 14A, filed on March 20, 2019).*

     

    *

    Previously filed.

    Get the next $GHL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GHL

    DatePrice TargetRatingAnalyst
    4/28/2022$16.50 → $12.00Mkt Perform → Underperform
    Keefe Bruyette
    3/9/2022$18.50 → $17.00Neutral
    Piper Sandler
    7/14/2021$15.50Underperform → Market Perform
    Keefe, Bruyette & Woods
    More analyst ratings

    $GHL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors

      Believes That Incremental Changes Since Last Annual Meeting Are Insufficient to Address the Poor Corporate Governance and Concerning Conflicts of Interest Threatening to Prevent NHI From Reaching its Full Value Potential Highlights the Urgent Need for NHI to Have Truly Independent Directors With the Right Expertise in the Boardroom Given Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details Concerns That NHC Lease Negotiations Will Not Reflect Market Value Given Board Member Conflicts; Lease Likely Has 75% Upside Based on Strong Coverage and Precedent Transactions and Could Boost Earnings 13% Or More Believes NHI Shares Have 50% Upside Over the Next

      2/19/25 8:00:00 AM ET
      $DOC
      $GHL
      $HCP
      $ING
      Real Estate Investment Trusts
      Real Estate
      Investment Bankers/Brokers/Service
      Finance
    • Greenhill & Co. Reports Second Quarter 2023 Results

      Announced definitive agreement for Greenhill to be acquired by Mizuho Financial Group, Inc. in an all-cash transaction at $15 per share Quarterly revenues of $71.4 million, up 98% from prior year's second quarter Year to date revenues of $121.1 million, up 49% from the same period in 2022 Compensation ratio of 54% for the quarter; 82% for the year to date period Operating margin of 21% for the quarter Recruited two additional Managing Directors during the quarter Greenhill & Co., Inc. (NYSE:GHL) today reported revenues of $71.4 million, net income of $4.4 million and diluted earnings per share of $0.21 for the quarter ended June 30, 2023. The Firm's second quarter

      8/9/23 4:05:00 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Lifshitz Law PLLC Announces Investigations of CWBR, GHL, PDCE, and VECT

      NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of CWBR and Morphogenesis, Inc. Under the terms of the proposed merger, CWBR shareholders will receive a dividend equal to approximately 3.30 shares of CWBR common stock. Following the merger, pre-merger CohBar shareholders are expected to own approximately 15% of the outstanding equity of the combined company. If you are a CWBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-

      6/3/23 8:17:00 PM ET
      $CWBR
      $GHL
      $PDCE
      $VECT
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Greenhill downgraded by Keefe Bruyette with a new price target

      Keefe Bruyette downgraded Greenhill from Mkt Perform to Underperform and set a new price target of $12.00 from $16.50 previously

      4/28/22 6:12:12 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Piper Sandler reiterated coverage on Greenhill & Co with a new price target

      Piper Sandler reiterated coverage of Greenhill & Co with a rating of Neutral and set a new price target of $17.00 from $18.50 previously

      3/9/22 6:45:52 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Greenhill & Co upgraded by Keefe, Bruyette & Woods with a new price target

      Keefe, Bruyette & Woods upgraded Greenhill & Co from Underperform to Market Perform and set a new price target of $15.50

      7/14/21 5:05:57 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Greenhill & Co. Inc. (Amendment)

      SC 13G/A - GREENHILL & CO INC (0001282977) (Subject)

      7/17/23 4:18:36 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13D/A filed by Greenhill & Co. Inc. (Amendment)

      SC 13D/A - GREENHILL & CO INC (0001282977) (Subject)

      5/22/23 5:28:29 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by Greenhill & Co. Inc. (Amendment)

      SC 13G/A - GREENHILL & CO INC (0001282977) (Subject)

      1/9/23 11:41:53 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    Financials

    Live finance-specific insights

    See more
    • Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors

      Believes That Incremental Changes Since Last Annual Meeting Are Insufficient to Address the Poor Corporate Governance and Concerning Conflicts of Interest Threatening to Prevent NHI From Reaching its Full Value Potential Highlights the Urgent Need for NHI to Have Truly Independent Directors With the Right Expertise in the Boardroom Given Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details Concerns That NHC Lease Negotiations Will Not Reflect Market Value Given Board Member Conflicts; Lease Likely Has 75% Upside Based on Strong Coverage and Precedent Transactions and Could Boost Earnings 13% Or More Believes NHI Shares Have 50% Upside Over the Next

      2/19/25 8:00:00 AM ET
      $DOC
      $GHL
      $HCP
      $ING
      Real Estate Investment Trusts
      Real Estate
      Investment Bankers/Brokers/Service
      Finance
    • Greenhill & Co. Reports Second Quarter 2023 Results

      Announced definitive agreement for Greenhill to be acquired by Mizuho Financial Group, Inc. in an all-cash transaction at $15 per share Quarterly revenues of $71.4 million, up 98% from prior year's second quarter Year to date revenues of $121.1 million, up 49% from the same period in 2022 Compensation ratio of 54% for the quarter; 82% for the year to date period Operating margin of 21% for the quarter Recruited two additional Managing Directors during the quarter Greenhill & Co., Inc. (NYSE:GHL) today reported revenues of $71.4 million, net income of $4.4 million and diluted earnings per share of $0.21 for the quarter ended June 30, 2023. The Firm's second quarter

      8/9/23 4:05:00 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Lifshitz Law PLLC Announces Investigations of CWBR, GHL, PDCE, and VECT

      NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of CWBR and Morphogenesis, Inc. Under the terms of the proposed merger, CWBR shareholders will receive a dividend equal to approximately 3.30 shares of CWBR common stock. Following the merger, pre-merger CohBar shareholders are expected to own approximately 15% of the outstanding equity of the combined company. If you are a CWBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-

      6/3/23 8:17:00 PM ET
      $CWBR
      $GHL
      $PDCE
      $VECT
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Ferro Kevin returned 81,495 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - GREENHILL & CO INC (0001282977) (Issuer)

      12/1/23 9:08:03 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Wyles David returned 98,707 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - GREENHILL & CO INC (0001282977) (Issuer)

      12/1/23 9:05:56 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • Ekman Ulrika returned 10,205 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - GREENHILL & CO INC (0001282977) (Issuer)

      12/1/23 9:03:36 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance

    $GHL
    SEC Filings

    See more
    • SEC Form 15-12G filed by Greenhill & Co. Inc.

      15-12G - GREENHILL & CO INC (0001282977) (Filer)

      12/11/23 4:03:05 PM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form S-8 POS filed by Greenhill & Co. Inc.

      S-8 POS - GREENHILL & CO INC (0001282977) (Filer)

      12/1/23 8:44:25 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form S-8 POS filed by Greenhill & Co. Inc.

      S-8 POS - GREENHILL & CO INC (0001282977) (Filer)

      12/1/23 8:41:52 AM ET
      $GHL
      Investment Bankers/Brokers/Service
      Finance